National Health Investors, Inc.
NHI
$75.16
-$0.16-0.21%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 257.05M | 251.99M | 250.92M | 246.12M | 249.23M |
| Total Other Revenue | 78.54M | 77.86M | 76.09M | 73.57M | 71.16M |
| Total Revenue | 335.58M | 329.85M | 327.01M | 319.68M | 320.39M |
| Cost of Revenue | 11.58M | 11.51M | 11.63M | 11.72M | 10.88M |
| Gross Profit | 324.00M | 318.34M | 315.38M | 307.96M | 309.51M |
| SG&A Expenses | 21.79M | 21.03M | 20.48M | 19.92M | 19.82M |
| Depreciation & Amortization | 71.44M | 69.87M | 69.62M | 69.86M | 69.97M |
| Other Operating Expenses | 42.29M | 41.51M | 40.73M | 40.18M | 40.04M |
| Total Operating Expenses | 147.11M | 143.92M | 142.46M | 141.69M | 140.71M |
| Operating Income | 188.48M | 185.93M | 184.55M | 177.99M | 179.68M |
| Income Before Tax | 136.64M | 125.57M | 126.36M | 130.84M | 134.36M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 136.64 | 125.57 | 126.36 | 130.84 | 134.36 |
| Earnings from Discontinued Operations | -- | -- | -- | 20.00K | 20.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.35M | 1.22M | 1.23M | 1.26M | 1.27M |
| Net Income | 137.99M | 126.79M | 127.60M | 132.12M | 135.66M |
| EBIT | 188.48M | 185.93M | 184.55M | 177.99M | 179.68M |
| EBITDA | 259.92M | 255.80M | 254.17M | 247.85M | 249.65M |
| EPS Basic | 3.14 | 2.92 | 2.94 | 3.04 | 3.13 |
| Normalized Basic EPS | 1.86 | 1.85 | 1.83 | 1.75 | 1.78 |
| EPS Diluted | 3.12 | 2.91 | 2.93 | 3.04 | 3.12 |
| Normalized Diluted EPS | 1.85 | 1.84 | 1.83 | 1.75 | 1.78 |
| Average Basic Shares Outstanding | 175.38M | 173.65M | 173.56M | 173.56M | 173.56M |
| Average Diluted Shares Outstanding | 176.41M | 174.36M | 173.77M | 173.59M | 173.56M |
| Dividend Per Share | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Payout Ratio | 113.43% | 123.29% | 122.49% | 118.27% | 115.17% |